Hookipa Biotech raises Series B led by Sofinnova and Forbion Capital

Hookipa Biotech has raised 20 million euros ($27.5 million) in a series B equity financing. Existing investors Sofinnova Partners and Forbion Capital Partners led the financing with three new investors Boehringer Ingelheim Venture Fund, Takeda Ventures and BioMedPartners joining the round.

North AmericaUSBriefs